SG Americas Securities’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $50.6M | Sell |
559,479
-421,130
| -43% | -$35.3M | 0.03% | 350 |
|
|
2026
Q1 | $78.5M | Buy |
980,609
+387,127
| +65% | +$31.9M | 0.08% | 185 |
|
|
2025
Q4 | $50.6M | Buy |
593,482
+15,370
| +3% | +$1.26M | 0.06% | 231 |
|
|
2025
Q3 | $45M | Buy |
578,112
+557,878
| +2,757% | +$43.6M | 0.15% | 79 |
|
|
2025
Q2 | $1.58M | Sell |
20,234
-739,205
| -97% | -$55.1M | 0.01% | 891 |
|
|
2025
Q1 | $55M | Sell |
759,439
-252,697
| -25% | -$18.1M | 0.18% | 75 |
|
|
2024
Q4 | $74.9M | Buy |
1,012,136
+986,675
| +3,875% | +$69.1M | 0.31% | 34 |
|
|
2024
Q3 | $1.68M | Sell |
25,461
-58,861
| -70% | -$4.28M | 0.01% | 756 |
|
|
2024
Q2 | $7.79M | Sell |
84,322
-13,232
| -14% | -$1.17M | 0.05% | 395 |
|
|
2024
Q1 | $9.32M | Buy |
97,554
+68,556
| +236% | +$5.76M | 0.04% | 386 |
|
|
2023
Q4 | $2.21M | Sell |
28,998
-8,482
| -23% | -$590K | 0.02% | 639 |
|
|
2023
Q3 | $2.6M | Buy |
37,480
+1,734
| +5% | +$139K | 0.03% | 589 |
|
|
2023
Q2 | $3.37M | Buy |
35,746
+11,227
| +46% | +$976K | 0.03% | 514 |
|
|
2023
Q1 | $2.03M | Buy |
24,519
+15,914
| +185% | +$1.25M | 0.02% | 652 |
|
|
2022
Q4 | $642K | Sell |
8,605
-40,585
| -83% | -$3.13M | 0.01% | 1321 |
|
|
2022
Q3 | $4.07M | Buy |
49,190
+31,854
| +184% | +$3.07M | 0.05% | 301 |
|
|
2022
Q2 | $1.65M | Buy |
17,336
+9,907
| +133% | +$1.03M | 0.02% | 857 |
|
|
2022
Q1 | $875K | Sell |
7,429
-31,133
| -81% | -$3.49M | 0.01% | 1514 |
|
|
2021
Q4 | $5M | Buy |
38,562
+21,335
| +124% | +$2.49M | 0.03% | 494 |
|
|
2021
Q3 | $1.95M | Sell |
17,227
-29,741
| -63% | -$3.39M | 0.01% | 1289 |
|
|
2021
Q2 | $4.86M | Buy |
46,968
+39,285
| +511% | +$3.7M | 0.02% | 598 |
|
|
2021
Q1 | $643K | Sell |
7,683
-65,772
| -90% | -$5.56M | ﹤0.01% | 1833 |
|
|
2020
Q4 | $6.7M | Buy |
73,455
+57,298
| +355% | +$4.75M | 0.04% | 379 |
|
|
2020
Q3 | $1.29M | Sell |
16,157
-24,946
| -61% | -$1.95M | 0.01% | 1040 |
|
|
2020
Q2 | $2.84M | Sell |
41,103
-58,572
| -59% | -$4.16M | 0.02% | 618 |
|
|
2020
Q1 | $6.27M | Buy |
99,675
+92,706
| +1,330% | +$6.69M | 0.06% | 309 |
|
|
2019
Q4 | $542K | Buy |
6,969
+5,058
| +265% | +$395K | ﹤0.01% | 1706 |
|
|
2019
Q3 | $140K | Sell |
1,911
-208,068
| -99% | -$14.6M | ﹤0.01% | 2550 |
|
|
2019
Q2 | $12.9M | Buy |
209,979
+195,903
| +1,392% | +$11.8M | 0.09% | 206 |
|
|
2019
Q1 | $898K | Sell |
14,076
-68,229
| -83% | -$3.89M | 0.01% | 1364 |
|
|
2018
Q4 | $4.2M | Buy |
82,305
+26,664
| +48% | +$1.35M | 0.04% | 452 |
|
|
2018
Q3 | $3.23M | Buy |
55,641
+9,762
| +21% | +$477K | 0.02% | 807 |
|
|
2018
Q2 | $2.23M | Sell |
45,879
-107,973
| -70% | -$5.04M | 0.02% | 867 |
|
|
2018
Q1 | $7.16M | Buy |
153,852
+52,794
| +52% | +$2.29M | 0.06% | 282 |
|
|
2017
Q4 | $3.8M | Buy |
101,058
+83,676
| +481% | +$3.07M | 0.04% | 510 |
|
|
2017
Q3 | $633K | Sell |
17,382
-53,688
| -76% | -$2.05M | 0.01% | 1628 |
|
|
2017
Q2 | $2.8M | Sell |
71,070
-472,836
| -87% | -$17.3M | 0.03% | 674 |
|
|
2017
Q1 | $17.1M | Buy |
543,906
+440,763
| +427% | +$13.8M | 0.15% | 129 |
|
|
2016
Q4 | $3.22M | Buy |
103,143
+87,882
| +576% | +$2.85M | 0.03% | 671 |
|
|
2016
Q3 | $613K | Sell |
15,261
-11,922
| -44% | -$449K | 0.01% | 1540 |
|
|
2016
Q2 | $904K | Sell |
27,183
-29,388
| -52% | -$1.01M | 0.01% | 1369 |
|
|
2016
Q1 | $1.66M | Sell |
56,571
-60,918
| -52% | -$1.68M | 0.01% | 976 |
|
|
2015
Q4 | $3.09M | Buy |
117,489
+94,461
| +410% | +$2.45M | 0.02% | 528 |
|
|
2015
Q3 | $546K | Sell |
23,028
-5,286
| -19% | -$128K | ﹤0.01% | 1035 |
|
|
2015
Q2 | $672K | Sell |
28,314
-17,514
| -38% | -$395K | ﹤0.01% | 1279 |
|
|
2015
Q1 | $1.09M | Sell |
45,828
-429,654
| -90% | -$9.64M | 0.01% | 1108 |
|
|
2014
Q4 | $10.1M | Buy |
475,482
+31,962
| +7% | +$642K | 0.05% | 388 |
|
|
2014
Q3 | $7.55M | Sell |
443,520
-132,750
| -23% | -$2.1M | 0.04% | 385 |
|
|
2014
Q2 | $8.24M | Sell |
576,270
-166,842
| -22% | -$2.26M | 0.05% | 392 |
|
|
2014
Q1 | $9.19M | Buy |
743,112
+51,090
| +7% | +$590K | 0.04% | 471 |
|
|
2013
Q4 | $7.58M | Sell |
692,022
-124,278
| -15% | -$1.4M | 0.03% | 509 |
|
|
2013
Q3 | $9.47M | Buy |
816,300
+244,470
| +43% | +$2.86M | 0.04% | 428 |
|
|
2013
Q2 | $6.4M | Buy |
+571,830
| New | +$6.77M | 0.03% | 508 |
|
Other funds holding EW
SG Americas Securities's EW Position: Q2 2026 in Review
SG Americas Securities reduced its Edwards Lifesciences (EW) stake by 43% in Q2 2026, selling an estimated $35.3M and leaving 559,479 shares worth $50.6M. The position accounts for 0.03% of the portfolio, ranked #350.
SG Americas Securities first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $78.5M in Q1 2026. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- SG Americas Securities held 559,479 shares of Edwards Lifesciences worth $50.6M as of Q2 2026.
- SG Americas Securities sold 421,130 Edwards Lifesciences shares in Q2 2026, an estimated $35.3M.
- Edwards Lifesciences made up 0.03% of SG Americas Securities's portfolio in Q2 2026, its #350 holding.
- SG Americas Securities first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- SG Americas Securities's Edwards Lifesciences position peaked at $78.5M in Q1 2026.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.